Umbilical cord is used in place of a bone marrow transplant in the treatment of blood disorders such as leukemia, with donations released for transplant through one registry, Netcord.org, passing 1,000,000 as of January 2013. Cord blood is used when the patient cannot find a matching bone marrow donor; this "extension" of the donor pool has driven the expansion of public banks. The umbilical cord in some mammals, including cows and sheep, contains two distinct umbilical veins. There is only one umbilical vein in the human umbilical cord. In some animals, the mother will gnaw through the cord, thus separating the placenta
Umbilical cord delayed cord clamping, and recommended policies be in place to monitor for and treat neonatal jaundice. ACOG also noted that delayed cord clamping is not associated with increased risk of postpartum hemorrhage. Several studies have shown benefits of delayed cord clamping: A meta-analysis showed that delaying clamping of the umbilical cord in full-term neonates for a minimum of 2 minutes following birth is beneficial to the newborn in giving improved hematocrit, iron status as measured by ferritin concentration and stored iron, as well as a reduction in the risk of anemia (relative risk, 0.53; 95% CI, 0.40–0.70). A decrease was